Synthesis and pharmacological activity of urea and thiourea derivatives of 4-azatricyclo[5.2.2.02,6]undec-8-ene-3,5-dione

Chemical and Pharmaceutical Bulletin

Volumn 55, Issue 5, 2007, Pages 796-799

  Struga, Marta ^a   Kossakowski, Jerzy ^a   Kȩdzierska, Ewa ^b   Fidecka, Sylwia ^a   Stefańska, Joanna ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Antimicrobial activity; Cytotoxicity; Pharmacological activity; Thiourea derivative; Urea derivative

Indexed keywords

1 (1 ISOPROPYL 7 METHYL 3,5 DIOXO 4 AZA TRICYCLO[5.2.2.0 2,6]UNDEC 8 EN 4 YL) 3 (4 METHOXY PHENYL)THIOUREA; 1 (1 ISOPROPYL 7 METHYL 3,5 DIOXO 4 AZA TRICYCLO[5.2.2.0 2,6]UNDEC 8 EN 4 YL) 3 (4 METHOXY PHENYL)UREA; 1 (1,7,8,9,10 PENTAMETHYL 3,5 DIOXO 4 AZA TRICYCLO[5.2.1.0 2,6]DEC 8 EN 4 YL) 3 PHENYL UREA; 1 (10 ISOPROPYL 8 METHYL 3,5 DIOXO 4 AZA TRICYCLO[5.2.2.0 2,6]UNDEC 8 EN 4 YL) 3 (4 METHOXY PHENYL)THIOUREA; 1 (10 ISOPROPYL 8 METHYL 3,5 DIOXO 4 AZA TRICYCLO[5.2.2.0 2,6]UNDEC 8 EN 4 YL) 3 (4 METHOXY PHENYL)UREA; 1 (4 METHOXY PHENYL) 3 (1,7,8,9,10 PENTAMETHYL 3,5 DIOXO 4 AZA TRICYCLO[5.2.1.0 2,6]DEC 8 EN 4 YL)THIOUREA; 1 (4 METHOXY PHENYL) 3 (1,7,8,9,10 PENTAMETHYL 3,5 DIOXO 4 AZA TRICYCLO[5.2.1.0 2,6]DEC 8 EN 4 YL)UREA; 1 ISOPROPYL 7 METHYL 4 AZATRICYCLO[5.2.2.0 2,6]UNDEC 8 EN 3,5 DIONE; 1,7,8,9,10 PENTAMETHYL 4 AZATRICYCLO[5.2.2.0 2,6]DEC 8 EN 3,5 DIONE; 10 ISOPROPYL 8 METHYL 4 AZATRICYCLO[5.2.2.0 2,6]UNDEC 8 EN 3,5 DIONE; THIOUREA DERIVATIVE; UNCLASSIFIED DRUG; UREA DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE;

ANIMALS; ANTI-HIV AGENTS; ANTI-INFECTIVE AGENTS; ANTICONVULSANTS; ANTINEOPLASTIC AGENTS; BEHAVIOR, ANIMAL; CANDIDA ALBICANS; CENTRAL NERVOUS SYSTEM AGENTS; CULTURE MEDIA; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HETEROCYCLIC COMPOUNDS, 3-RING; HIV; INDICATORS AND REAGENTS; LETHAL DOSE 50; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MICROBIAL SENSITIVITY TESTS; MOTOR ACTIVITY; THIOUREA; UREA;

EID: 34248196943     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.55.796     Document Type: Article

References (36)

1. Venkatachalam T. K., Mao C., Uckun F. M., Bioorg. Med. Chem., 12, 4275-4284 (2004).
2. Bloom J. D., Dushin R. G., Curran K. J., Donahue F., Norton E. B., Terefenko E., Jonas T. R., Ross A. A., Feld B., Lang S. A., DiGrandi M. J., Bioorg. Med. Chem., 14, 3401-3406 (2004).
3. Seth P. P., Ranken R., Robinson D. E., Osgood S. A., Risen L. M., Rodgers E. L., Migawa M. T., Jefferson E. A., Swayze E. E., Bioorg. Med. Chem., 14, 5569-5572 (2004).
4. Lee J., Lee J., Kang M., Shin M., Kim J. M., Kang S. U., Lim J. O., Choi H. K., Suh Y. G., Park H. G., Oh U., Kim H. D., Park Y. H., Ha H. J., Kim Y. H., Toth A., Tran R., Pearce L. V., Lundberg D. J., Blumberg P. M., J. Med. Chem., 46, 3116-3126 (2003).
5. Forbes I. T., Ham P., Booth D. H., Martin R. T., Thompson M., Baxter G. T., Blackburn T. P., Glen A., Kennet G. A., Wood M. D., J. Med. Chem., 25, 2524-2530 (1995).
6. Nozulak J., Walkman H. O., Floerscheim P., Hoyer D., Schoeffer P., Buerki H. R., J. Med. Chem., 38, 28-33 (1995).
7. Forbes I. T., Jones G. E., Murphy O. E., Holland V., Barter G. S., J. Med. Chem., 38, 855-857 (1995).
8. Fludzinski P., Wittenauer L. A., Schenck K. W., Cohen M. L., J. Med. Chem., 29, 2415-2418 (1986).
9. Audia J. E., Evrard D. A., Murdoch G. R., Droste J. J., Nissen J. S., Schenck K. W., Fludzinski P., Lucaites V. L., Nelson D. L., Cohen M. L., J. Med. Chem., 39, 2773-2780 (1996).
10. Corne S. J., Pickering R. W., Warner B. T., Brit. J. Pharmacol, 20, 106-120 (1963).
11. Corne S. J., Pickering R. W., Psychopharmacologia, 11, 65-78 (1967).
12. Peroutka S. J., Lebovitz R. M., Snyder S. H., Science, 212, 827-829 (1981).
13. Colpaert F. C., Janssen P. A. J., Neuropharmacology, 22, 993-1000 (1983).
14. Green A. R., O'Shaughnessy K., Hammond M., Schachter M., Grahame-Smith D. G., Neuropharmacology, 22, 573-578 (1983).
15. Goodwin G. M., Green A. R., Brit. J. Pharmacol., 84, 743-755 (1985).
16. Darmani N. A., Martin B. R., Glennon R. A., Eur. J. Pharmacol., 186, 115-118 (1990).
17. Darmani N. A., Martin B. R., Pandy U., Glennon R. A., Pharmacol. Biochem. Behav., 36, 901-906 (1990).
18. Darmani N. A., Martin B. R., Glennon R. A., J. Pharmacol. Exp. Ther., 262, 692-698 (1992).
19. Fantegrossi W. E., Kiessel C. L., Leach P. T., Van Martin C., Karabenick R. L., Chen X., Ohizumi Y., Ullrich T., Rice K. C., Woods J. H., Psychopharmacology, 173, 270-277 (2004).
20. Lucki I., Nobler M. S., Frazer A., J. Pharmacol. Exp. Ther., 228, 133-139 (1984).
21. Handley S. L., Singh L., Pharmacol. Sci., 7, 324-328 (1986).
22. Ortmann R., Biscoff S., Radeke E., Bueche O., Delini-Stula A., Naunyn Schmiedeberg's Arch. Pharmacol., 321, 265-270 (1982).
23. Zawadowski T., Skowron A. A., Suski S., Rump S., Jakowicz J., Acta Pol. Pharm., 52, 129-132 (1995).
24. Kossakowski J., Kuśmierczyk J., Pharmazie, 55, 5-8 (2000).
25. Orzeszko A., Kamieńska B., Orzeszko G., Starościak B. J., Farmaco, 55, 619-623 (2000).
26. Furmanowa M., Nosow A. M., Oreshnikow A. V., Kluski A. G., Kotin M., Statrościak B. J., Śliwińska A., Guzewska J., Bloch R., Pharmazie, 57, 424-426 (2002).
27. Orzeszko A., Kamieńska B., Starościak B. J., Farmaco, 57, 619-624 (2002).
28. Struga M., Mirosław B., Wawrzycka-Gorczyca I., Kossakowski J., Kozioł A. E., Polish J. Chem., 81, 51-59 (2007).
29. Vogel G. H., Vogel W. H., "Drug Discovery and Evaluation. Pharmacological Assays," Springer-Verlag, Berlin, 1997.
30. Litchfield L. T., Wilcoxon F., J. Pharmacol. Exp. Ther., 96, 99-113 (1949).
31. Koster R., Anderson M., DeBeer E. J., Fed. Proc., 18, 412-418 (1959).
32. Gross F., Tripod J., Meir R., Doriden. Schweiz. Med. Wochschr., 85, 305-309 (1995).
33. Boissier J. R., Tardy J., Diverres J. C., Med. Exp. (Basel), 3, 81-84 (1960).
34. Corne S. J., Pickering R. W., Werner B. T., Brit. J. Pharmacol., 20, 106-120 (1963).
35. Pauwels P., Balzarini J., Baba M., Snoeck R., Schols R. D., Herdewijn P., Desmyster J., De Clercq E., J. Virol. Methods, 20, 309-321 (1988).
36. Clinical and Laboratory Standards Institute, Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard-Eighth Edition, Villanova, PA, U.S.A. 2003.